Drug
Endoxifen clinical trials
Includes 3 studies of Endoxifen hydrochloride.
- studies test it
- 10
- open now
- 3
- in phase 3
- 1
- first study started
- 2010
Keep track of what changes. Save the endoxifen studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
9 studies that test it; most in 2011 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2015 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 6
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 6
National Cancer Institute (NCI) (4) · Atossa Therapeutics, Inc. (3) · QuantumLeap Healthcare Collaborative (2) · Jina Pharmaceuticals Inc. (1)
Often tested with
Tested in the same studies.
Tamoxifen (1) · Anastrozole (1) · Testosterone (1) · Elacestrant (1) · Trebananib (1) · Trastuzumab (1) · Ado-Trastuzumab Emtansine (1) · Pertuzumab (1)
Studies
Open first, then newest update. How each study uses endoxifen is read from its arms, and is right about nine times in ten.
Testing it · 10
- (Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious PubertyNot yet recruitingPhase 2Atossa Therapeutics, Inc.NCT07869732Written as (Z)-endoxifen
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentRecruitingPhase 2QuantumLeap Healthcare CollaborativeNCT06075953Written as Z-endoxifen
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerRecruitingPhase 2QuantumLeap Healthcare CollaborativeNCT01042379Written as Z-endoxifen
- Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerActive, not recruitingPhase 2National Cancer Institute (NCI)NCT02311933Written as Endoxifen Hydrochloride
- Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast SurgeryActive, not recruitingPhase 1National Cancer Institute (NCI)NCT03317405Written as Endoxifen Hydrochloride
- Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast CancerActive, not recruitingPhase 1National Cancer Institute (NCI)NCT01327781Written as Endoxifen Hydrochloride
- Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast DensityCompletedPhase 2Atossa Therapeutics, Inc.NCT05068388Written as Z-Endoxifen
- Endoxifen in Adults With Hormone Receptor Positive Solid TumorsCompletedPhase 1National Cancer Institute (NCI)NCT01273168Written as Z-Endoxifen
- Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder PatientsCompletedPhase 3Jina Pharmaceuticals Inc.NCT04315792Written as Endoxifen
- Topical Endoxifen in WomenCompletedPhase 2Atossa Therapeutics, Inc.NCT04616430Written as Topical endoxifen
Given in every arm · 1 — endoxifen is usual care beside what is tested
Codes
What other systems call endoxifen · ClinicalTrials.gg INT003372
- MeSH (NLM) C0554924-hydroxy-N-desmethyltamoxifenConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 46AF8680RCENDOXIFENConfirmed FDA, NLM, Wikidata
- Wikidata Q27149598endoxifenConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C221983EndoxifenOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C055492 | 4-hydroxy-N-desmethyltamoxifen | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 46AF8680RC | ENDOXIFEN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27149598 | endoxifen | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C221983 | Endoxifen | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.